• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓素A2受体拮抗剂S-145及相关化合物分子内氢键的傅里叶变换红外光谱研究。3. S-145类似物的构象与活性

FTIR spectral study of intramolecular hydrogen bonding in thromboxane A2 receptor antagonist S-145 and related compounds. 3. Conformation and activity of S-145 analogues.

作者信息

Takasuka M, Yamakawa M, Ohtani M

机构信息

Shionogi Research Laboratories, Shionogi & Company, Ltd., Osaka, Japan.

出版信息

J Med Chem. 1991 Jun;34(6):1885-91. doi: 10.1021/jm00110a020.

DOI:10.1021/jm00110a020
PMID:1829486
Abstract

S-145, (+/-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo[2.2.1] heptenoic acid, its chain analogues HO2C(CH2)nNHSO2Ph (n = 3-8, 10, and 11) 1-8, and (5Z)-9-(phenylsulfonyl) aminonon-5-enoic acid (9) were synthesized in order to elucidate the dependence of the conformation in solution and of the pharmacological activity on the side-chain length. Their FTIR spectra were measured in dilute CCl4 solution. For these compounds, intramolecular hydrogen bonds similar to those observed for S-145 were found between the carboxyl and sulfonamido groups. A linear relationship was also found between the percentage (rho) of the intramolecular hydrogen-bonded molecules and the n value. Compounds 1-9 were examined in vitro for inhibitory concentrations (IC50) against U-46619- and collagen-induced aggregations for rabbit and rat washed platelets (WP), respectively, and U-46619-induced contraction for rat aorta. Three kinds of TXA2 receptor antagonistic potencies [log(1/IC50)] showed parabolic correlations with the n value, though the rho value was in direct proportion to the n value. The log (1/IC50) values for 6 (n = 8), which forms a 12-membered ring similar to the one observed for S-145, were found to be maximal values in 1-8 and were comparable to those for BM-13177. In compounds 9 (rho = 83%) and S-145 (rho = 89%), the IC50 values of 41 and 2.9 nM for rat WP were 10 and 141 times lower than that of 6 (rho = 52%), respectively. In these compounds, which form the 12-membered ring, the inhibitory potencies increase as the rho value increases.

摘要

S-145,(±)-(5Z)-7-[3-内-[(苯磺酰基)氨基]双环[2.2.1]庚烯酸、其链类似物HO2C(CH2)nNHSO2Ph(n = 3 - 8、10和11)1 - 8以及(5Z)-9-(苯磺酰基)氨基壬-5-烯酸(9)被合成出来,以阐明溶液中的构象以及药理活性对侧链长度的依赖性。它们的傅里叶变换红外光谱在稀四氯化碳溶液中测量。对于这些化合物,在羧基和磺酰胺基之间发现了与S-145中观察到的类似的分子内氢键。分子内氢键结合分子的百分比(rho)与n值之间也发现了线性关系。分别在体外检测了化合物1 - 9对兔和大鼠洗涤血小板(U-46619和胶原诱导聚集)以及大鼠主动脉U-46619诱导收缩的抑制浓度(IC50)。三种血栓素A2受体拮抗效力[log(1/IC50)]与n值呈抛物线相关性,尽管rho值与n值成正比。对于形成与S-145中观察到的类似的12元环的6(n = 8),其log(1/IC50)值在1 - 8中为最大值,并且与BM-13177的相当。在化合物9(rho = 83%)和S-145(rho = 89%)中,大鼠洗涤血小板的IC50值分别为41和2.9 nM,比6(rho = 52%)的低10倍和141倍。在这些形成12元环的化合物中,抑制效力随着rho值的增加而增加。

相似文献

1
FTIR spectral study of intramolecular hydrogen bonding in thromboxane A2 receptor antagonist S-145 and related compounds. 3. Conformation and activity of S-145 analogues.血栓素A2受体拮抗剂S-145及相关化合物分子内氢键的傅里叶变换红外光谱研究。3. S-145类似物的构象与活性
J Med Chem. 1991 Jun;34(6):1885-91. doi: 10.1021/jm00110a020.
2
Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (+/-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo[2.2.1] hept-2-exo-yl]heptenoic acid.
J Med Chem. 1988 Sep;31(9):1847-54. doi: 10.1021/jm00117a028.
3
Synthesis and in vitro activity of stereoisomers of a novel thromboxane receptor antagonist, (+-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo [2.2.1]hept-2-exo-yl]heptenoic acid.一种新型血栓素受体拮抗剂(±)-(5Z)-7-[3-内-[(苯磺酰基)氨基]双环[2.2.1]庚-2-外-基]庚烯酸的立体异构体的合成及体外活性
J Med Chem. 1990 Mar;33(3):1027-31. doi: 10.1021/jm00165a022.
4
FTIR spectral study of intramolecular hydrogen bonding in thromboxane A2 receptor agonist (U-46619), prostaglandin (PG)E2, PGD2, PGF2 alpha, prostacyclin receptor agonist (carbacyclin), and their related compounds in dilute CCl4 solution: structure-activity relationships.
J Med Chem. 1994 Jan 7;37(1):47-56. doi: 10.1021/jm00027a006.
5
7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.7-[(1R,2S,3S,5R)-6,6-二甲基-3-(4-碘苯磺酰氨基)双环[3.1.1]庚-2-基]-5(Z)-庚烯酸:一种新型的血小板血栓素A2/前列腺素H2受体高亲和力放射性标记拮抗剂。
J Pharmacol Exp Ther. 1992 Aug;262(2):632-7.
6
Synthesis of thromboxane receptor antagonists with bicyclo[3.1.0]hexane ring systems.
J Med Chem. 1990 Jan;33(1):229-39. doi: 10.1021/jm00163a038.
7
Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets.新型化合物S - 145作为血小板中特异性血栓素A2受体拮抗剂的特性研究
Thromb Res. 1988 May 1;50(3):365-76. doi: 10.1016/0049-3848(88)90266-6.
8
Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors.S-145对血管和血小板血栓素A2受体的拮抗作用。
Eur J Pharmacol. 1989 Nov 21;171(2-3):179-87. doi: 10.1016/0014-2999(89)90106-4.
9
In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.新型血栓素A2/前列腺素H2(TXA2/PGH2)部分激动剂(+)5(Z)-7-[3-内苯基磺酰氨基[2.2.1]双环庚-2-外基]-庚烯酸[(+)-S-145]对血管、血小板和心脏功能的体内作用
J Pharmacol Exp Ther. 1995 Feb;272(2):799-807.
10
[Effect of (+)-S-145 calcium salt dihydrate, an orally active antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation].[血栓素A2/前列腺素内过氧化物受体口服活性拮抗剂(+)-S-145二水合钙盐对血小板聚集的影响]
Nihon Yakurigaku Zasshi. 1991 Aug;98(2):113-20. doi: 10.1254/fpj.98.2_113.